Pubblicazioni - Ornaghi Dott. Diego

• Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease.
  Am J Cardiol

  2017 05;119(9):1438-1442. doi: S0002-9149(17)30141-8.
  
  Conrotto Federico, Salizzoni Stefano, Andreis Alessandro, D'Ascenzo Fabrizio, D'Onofrio Augusto, Agrifoglio Marco, Chieffo Alaide, Colombo Antonio, Rapetto Filippo, Santini Francesco, Tarantini Giuseppe, Gabbieri Davide, Savini Carlo, Immè Sebastiano, Ribichini Flavio, Valsecchi Orazio, Aiello Marco, Lixi Giovanni, Iadanza Alessandro, Pompei Esmeralda, Stolcova Miroslava, Ornaghi Diego, Minati Alessandro, Cassese Mauro, Martinelli Gian Luca, Sbarra Pierluigi, Agostinelli Andrea, Audo Andrea, Pieroni Andrea, Fiorilli Rosario, Gerosa Gino, Rinaldi Mauro, Gaita Fiorenzo
  
  Abstract
  
  Advanced chronic kidney disease (CKD) is associated with poor outcomes in patients who underwent surgical aortic valve replacement, whereas its prognostic role in transcatheter aortic valve implantation (TAVI) remains unclear. This study aimed to investigate outcomes in patients with advanced CKD who underwent TAVI. A total of 1,904 consecutive patients who underwent balloon-expandable TAVI in 33 centers between 2007 and 2012 were enrolled in the Italian Transcatheter Balloon-Expandable Valve Implantation Registry. Advanced CKD was defined according to the estimated glomerular filtration rate: 15 to 29 ml/min/1.73 m stage 4 (S4), <15 ml/min/1.73 m stage 5 (S5). Edwards Sapien or Sapien-XT prosthesis were used. The primary end point was all-cause mortality during follow-up. Secondary end points were major adverse cardiac events at 30 days and at follow-up, defined with Valve Academic Research Consortium 2 criteria. A total of 421 patients were staged S5 (n = 74) or S4 (n = 347). S5 patients were younger and had more frequently porcelain aorta and a lower incidence of previous stroke. Periprocedural and 30-day outcomes were similar in S5 and S4 patients. During 670 (±466) days of follow-up, S5 patients had higher mortality rates (69% vs 39%, p <0.01) and cardiac death (19% vs 9%, p = 0.02) compared with S4 patients. Male gender (hazard ratio [HR] 1.6, 95% confidence interval [CI] 1.2 to 2.2), left ventricular ejection fraction <30% (HR 2.3, 95% CI 1.3 to 4), atrial fibrillation (HR 1.4, 95% CI 1.0 to 1.9), and S5 CKD (HR 1.5, 95% CI 1.0 to 2.1) were independent predictors of death. In conclusion, TAVI in predialytic or dialytic patients (i.e., S5) is independently associated with poor outcomes with more than double risk of death compared with patients with S4 renal function. Conversely, in severe CKD (i.e., S4) a rigorous risk stratification is required to avoid the risk of futility risk.
  
  Copyright © 2017 Elsevier Inc. All rights reserved.
  
  Guarda su PubMed

• Impact of Cusp Repair on Reoperation Risk After the David Procedure.
  Ann Thorac Surg

  2016 Nov;102(5):1503-1511. doi: S0003-4975(16)30391-5.
  
  Settepani Fabrizio, Cappai Antioco, Basciu Alessio, Barbone Alessandro, Moz Monica, Citterio Enrico, Ornaghi Diego, Tarelli Giuseppe
  
  Abstract
  
  BACKGROUND:
  We assessed whether additional cusp repair during valve-sparing aortic root replacement affects the echocardiographic mid-term results; a subgroup analysis among patients with bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) was performed.
  
  METHODS:
  Between June 2002 and May 2015, 157 consecutive patients underwent valve-sparing aortic root replacement with the David technique. Thirty patients (19%) had BAV. In 19 patients (12%), cusp motion or anatomic abnormalities contributed in determining aortic regurgitation requiring an additional cusp repair. Mean follow-up was 7 ± 3.4 years.
  
  RESULTS:
  The cumulative 1-, 5-, and 12-year survival rates were 98%, 94%, and 90%, respectively. Fourteen patients (9%) required aortic valve replacement during follow-up. In 2 patients the underlying cause was bacterial endocarditis. Freedom from aortic valve reoperation was 96% at 1 year, 92% at 5 years, and 89% at 12 years. Reoperation rate was significantly higher (p < 0.001) in patients who received leaflet repair compared with patients who did not, with a freedom from reoperation at 8 years of 58% versus 94%. Among patients with BAV, those who did not require cusp repair had a freedom from reoperation at 8 years of 94%, with a significant difference compared with patients who received cusp repair (p = 0.04). Cusp repair did not affect reoperation risk in patients with tricuspid aortic valve.
  
  CONCLUSIONS:
  Adjunctive cusp repair seems to affect the mid-term reoperation risk in patients with BAV and not in patients with tricuspid aortic valve. We recommend caution in using this technique in case of asymmetric BAV requiring cusp repair.
  
  Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  
  Guarda su PubMed

• Iatrogenic left ventricular false aneurysm.
  J Cardiovasc Med (Hagerstown)

  2016 Dec;17 Suppl 2():e158. doi: 10.2459/JCM.0000000000000310.
  
  Cappai Antioco, Settepani Fabrizio, Barbone Alessandro, Ornaghi Diego, Malvindi Pietro Giorgio
  
  Abstract
  
  : We present a false aneurysm of ventricular left apex after mitral valve in valve prosthesis transapical implantation.
  
  Guarda su PubMed

• Hybrid Versus Conventional Treatment of Acute Type A Aortic Dissection.
  J Card Surg

  2015 Sep;30(9):707-13. doi: 10.1111/jocs.12598.
  
  Settepani Fabrizio, Cappai Antioco, Basciu Alessio, Barbone Alessandro, Citterio Enrico, Ornaghi Diego, Tarelli Giuseppe
  
  Abstract
  
  BACKGROUND:
  To determine whether the hybrid approach to acute type A aortic dissection results in improved outcomes in terms of mortality, neurologic complications, need for distal aortic reintervention, and false lumen thrombosis compared with the conventional approach.
  
  METHODS:
  Data from comparative studies of hybrid versus conventional treatment of acute type A aortic dissection were combined through meta-analysis. Pooled odd ratios were calculated using random effects models.
  
  RESULTS:
  Seven comparative studies including 967 patients were identified; of these, 503 underwent conventional proximal aortic repair and 429 extensive distal aortic repair including a stented elephant trunk technique. Between the two groups there was no significant difference in operative mortality (p?=?0.96), permanent neurologic deficit (p?=?0.95), and late mortality (p?=?0.59). Distal aortic repair showed a higher rate of false lumen thrombosis of the thoracic aorta (odd ratio 11.16; p?
  CONCLUSIONS:
  Distal aortic repair may reduce the risk of distal reintervention and increase the rate of false lumen thrombosis without significant increase in operative mortality and permanent neurologic deficit; however, no benefit with respect to late mortality was found. The frozen elephant trunk may reduce the risk of distal aortic reintervention and may increase the false lumen thrombosis of the thoracic aorta in comparison with antegrade/retrograde stent deployment procedures.
  
  © 2015 Wiley Periodicals, Inc.
  
  Guarda su PubMed

• A Hybrid Double Access for Transcatheter Mitral Valve-In-Valve Implantation.
  Ann Thorac Surg

  2015 Jun;99(6):e149-50. doi: 10.1016/j.athoracsur.2015.02.101.
  
  Pagnotta Paolo, Mennuni Marco G, Ferrante Giuseppe, Ornaghi Diego, Bragato Renato, Cappai Antioco, Presbitero Patrizia
  
  Abstract
  
  We present a case of hybrid mitral valve-in valve implantation. The planned transapical approach failed due to the inability to cross the degenerated stenotic mitral bioprosthesis. An alternative strategy was performed: first, an anterograde crossing of mitral stenosis, and then, a guidewire externalization through the apex by using a snare. To our knowledge, this is the first described case of double approach mitral valve-in valve implantation.
  
  Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  
  Guarda su PubMed

• Transapical transcatheter valve-in-valve replacement for deteriorated mitral valve bioprosthesis without radio-opaque indicators: the "invisible" mitral valve bioprosthesis.
  Heart Lung Circ

  2015 Feb;24(2):e19-22. doi: 10.1016/j.hlc.2014.09.016.
  
  Rossi Marco Luciano, Barbaro Cristina, Pagnotta Paolo, Cappai Antioco, Ornaghi Diego, Belli Guido, Presbitero Patrizia
  
  Abstract
  
  In view of the high number of bioprosthetic valves implanted during the past 30 years, an increasing number of patients are coming to medical attention because of degenerated bioprostheses. Transcatheter aortic valve-in-valve implantation has been described as a less invasive alternative to re-operation to treat severe structural valve deterioration. As far as degenerated mitral valve bioprostheses are concerned, transcatheter transapical mitral valve-in-valve replacement (TMVR) has been less commonly performed, but may also become a viable alternative to re-do replacement surgery. We describe treatment of a degenerated bioprosthetic mitral valve, characterised by complete absence of any radio-opaque landmarks making the TMVR procedure very challenging.
  
  Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
  
  Guarda su PubMed

• Cusp repair during aortic valve-sparing operation: technical aspects and impact on results.
  J Cardiovasc Med (Hagerstown)

  2015 Apr;16(4):310-7. doi: 10.2459/JCM.0000000000000031.
  
  Settepani Fabrizio, Cappai Antioco, Raffa Giuseppe M, Basciu Alessio, Barbone Alessandro, Berwick Daniele, Citterio Enrico, Ornaghi Diego, Tarelli Giuseppe, Malvindi Pietro G
  
  Abstract
  
  AIMS:
  Aortic valve-sparing operations are nowadays considered safe and reliable procedures in terms of mid-term and long-term results. Although surgical techniques regarding the modality of grafts' implantation have been properly addressed, the modality of cusp repair, when needed, is still open to debate. We sought to review the literature to try to shed light on when the cusp repair is required and how it should be performed.
  
  METHODS:
  We searched the PubMed database using the keywords aortic valve-sparing operation, aortic valve-sparing reimplantation, valve-sparing aortic root replacement, aortic valve repair, and aortic cusp repair. Only studies that included and described in detail the technique of cusp repairs in adjunct to aortic valve-sparing operation were considered.
  
  RESULTS:
  Bicuspid aortic valve more often requires correction when compared with tricuspid valve. The range of the techniques varies from the 'simple' free margin plication to the more complex triangular resection with patch repair. Results in the literature seem to be encouraging, showing that, in most of the cases, cusp repair does not affect valve competence in the mid-term and long-term.
  
  CONCLUSION:
  Correction of the cusp is a delicate balance between undercorrection that could lead to residual prolapse and overcorrection that could lead to cusp restriction. Although complex repair of the aortic valve in addition to root replacement provided satisfactory results, it should be reserved for experienced centers with a large volume of patients.
  
  Guarda su PubMed

• An Unusual Left Ventricular Apical Mass.
  J Cardiovasc Echogr

  ;24(3):95-96. doi: 10.4103/2211-4122.143986.
  
  Cavallero Erika, Curzi Mirko, Cioccarelli Sara Anna, Papalia Giulio, Ornaghi Diego, Bragato Renato Maria
  
  Abstract
  
  Left ventricular apical masses constitute a rare finding. Imaging properties together with the clinical history of the patient usually allow an etiologic definition. We report a challenging case of an ambiguous left ventricular apical mass of uncertain nature till histological examination. Points of interest were singular clinical history and echocardiographic findings, although not conclusive in hypothesis generating. Furthermore to the best of our knowledge, this is one of the rare attempt to excise a deep left ventricular mass with a mini-invasive surgical approach.
  
  Guarda su PubMed

• [CircuLite Synergy ventricular assist device: a new approach to end-stage congestive heart failure].
  G Ital Cardiol (Rome)

  2014 Feb;15(2):116-22. doi: 10.1714/1424.15781.
  
  Barbone Alessandro, Pini Daniela, Ornaghi Diego, Visigalli Maria Maddalena, Ardino Laura, Bragato Renato, Curzi Mirko, Cioccarelli Sara Anna, Di Diodoro Lara, Basciu Alessio, Cappai Antioco, Settepani Fabrizio, Citterio Enrico, Cappelleri Alessio, Calcagnino Margherita, Mangiavacchi Maurizio, Tarelli Giuseppe, Lettino Maddalena, Vitali Ettore
  
  Abstract
  
  BACKGROUND:
  The Synergy system, a miniature partial circulatory support device, is implanted by an off-pump, minimally invasive surgical approach. The system has been optimized to improve performance in an EU clinical trial for chronic ambulatory heart failure. This therefore offers the possibility of treating elderly chronic heart failure patients who might not usually be considered for long-term circulatory support.
  
  METHODS:
  From June 2007 to December 2012, 63 patients were implanted with the Synergy system (12 patients ?70 years) using four different releases of the device. Briefly, the system draws blood through the inflow cannula from the left atrium into the micro-pump (placed in a right subclavicular pocket) and pumps it through an outflow graft to the right subclavian artery. In this paper, we present an intermediate analysis of the clinical trial as performed on April 30, 2013, leading to the placing of the CE mark.
  
  RESULTS:
  Mean duration of support is ongoing at 230 days (range 23-1387). Follow-up showed improved hemodynamic response, with additional improvements in 6-min walk distance (299 ± 144 to 420 ± 119 m) and Minnesota Living with Heart Failure Questionnaire (69.5 ± 20.4 to 49.2 ± 24.3). Older patients had longer mean durations of support (337 vs 188 days). On average, elderly and younger patients showed similar improvements in hemodynamics and 6-min walk distance (107 ± 120 vs 130 ± 121 m). Major adverse cardiac events included bleeding (n=4) with one bleeding related to renal failure resulting in death.
  
  CONCLUSIONS:
  Clinical use of the Synergy device was associated with a significant functional improvement. Very low adverse event rates were reported with the latest device release. Older patients had smaller body sizes and worse renal function than younger patients. Both groups experienced similar hemodynamic benefits and functional improvements. The risk of bleeding and renal dysfunction appears to be increased in the elderly, though still within acceptable ranges compared to other full support devices. Minimally invasive long-term circulatory support devices, like Synergy, offer a new treatment option that might be available even for the elderly chronic heart failure population.
  
  Guarda su PubMed

• Analysis of postsurgical aortic false aneurysm in 27 patients.
  Tex Heart Inst J

  2013 ;40(3):274-80.
  
  Malvindi Pietro Giorgio, Cappai Antioco, Raffa Giuseppe Maria, Barbone Alessandro, Basciu Alessio, Citterio Enrico, Ornaghi Diego, Tarelli Giuseppe, Settepani Fabrizio
  
  Abstract
  
  Aortic false aneurysm is a rare complication after cardiac surgery. In recent years, improved results have been reported in regard to the surgical management of these high-risk lesions. We retrospectively examined 28 consecutive cases (in 27 patients) of postsurgical aortic false aneurysm diagnosed at our institution from May 1999 through December 2011. Twenty-four patients underwent reoperation. Cardiopulmonary bypass was instituted before sternotomy in 15 patients (63%). Isolated repair of the aortic false aneurysm was performed in 15 patients. Four patients (including one who had already undergone repeat false-aneurysm repair) declined surgery in favor of clinical monitoring. Eleven patients were asymptomatic at the time of diagnosis. In the other 16, the main cause was infection in 7, and previous operation for acute aortic dissection in 9. The in-hospital mortality rate was 16.6% (4 patients, 3 of whom had infective false aneurysms). Relevant postoperative sequelae were noted in 7 patients (29%). The cumulative 1-year and 5-year survival rates were 83% and 62%, respectively. The 4 patients who did not undergo reoperation were alive at a median interval of 23 months (range, 9-37 mo). Two underwent imaging evaluations; in one, computed tomography revealed an 8-mm increase of the false aneurysm's maximal diameter at 34 months. Aortic false aneurysm can develop silently. Surgical procedures should be proposed even to asymptomatic patients because of the unpredictable evolution of the condition. Radical aortic-graft replacement should be chosen rather than simple repair, because recurrent false aneurysm is possible.
  
  Guarda su PubMed

• Minimally invasive direct coronary artery bypass in the era of percutaneous coronary intervention.
  J Cardiovasc Med (Hagerstown)

  2015 Feb;16(2):118-24. doi: 10.2459/JCM.0b013e3283630c60.
  
  Raffa Giuseppe M, Malvindi Pietro G, Ornaghi Diego, Citterio Enrico, Cappai Antioco, Basciu Alessio, Barbone Alessandro, Fossati Francesca, Tarelli Giuseppe, Settepani Fabrizio
  
  Abstract
  
  AIM:
  Minimally invasive coronary artery bypass (MIDCAB) allows revascularization of the left anterior descending coronary (LAD) artery through a less traumatic surgical approach. However, the procedure is technically challenging and concern still exists, mainly based on graft patency. The purpose of this study is to critically evaluate short and long-term benefits of this surgical treatment.
  
  METHODS:
  Between June 1997 and July 2012, 306 patients underwent MIDCAB on LAD. The mean age was 62?±?10 years (range, 32-87 years) and 264 patients (86.3%) were men. Mean ejection fraction was 54%. Eighty-nine procedures (29.1%) were performed using a hybrid approach by means of MIDCAB and postoperative (60 patients, 67.4%) or preoperative (29 patients, 32.6%) percutaneous interventions on non-LAD vessels. A EuroScore more than 6 was found in 43 (14%) patients. The average follow-up time was 9.5?±?3.2 years and was 89% complete.
  
  RESULTS:
  Six patients (1.9%) required intraoperative conversion to sternotomy, whereas cardiopulmonary bypass institution after the sternotomy was necessary in one. Postoperative acute myocardial infarction occurring nine patients (2.9%), low output syndrome in four (1.3%). Postoperative mortality was 1.6% (n?=?5), and perioperative stroke rate 0.6% (n?=?2). Five and 10-year survival were 94.1 and 86.9%, respectively. Freedom from death due to cardiac events and major cardiac and cerebral events at 10 years was, respectively, 97.1 and 92.1%.
  
  CONCLUSIONS:
  The results confirm the favorable short and long-term results of the MIDCAB procedure. MIDCAB, in experienced centers, can represent an alternative treatment option for LAD disease.
  
  Guarda su PubMed

• Circulatory support in elderly chronic heart failure patients using the CircuLite® Synergy® system.
  Eur J Cardiothorac Surg

  2013 Aug;44(2):207-12; discussion 212. doi: 10.1093/ejcts/ezt041.
  
  Barbone Alessandro, Pini Daniela, Rega Filip, Ornaghi Diego, Vitali Ettore, Meyns Bart
  
  Abstract
  
  OBJECTIVE:
  The Synergy(®) system, a miniature partial circulatory support device, is implanted with an off-pump, minimally invasive surgical approach. In our experience, implantation of this system is associated with fewer perioperative adverse events than current full support devices. This approach therefore offers the possibility of treating elderly chronic heart-failure patients who might not ordinarily be considered for long-term circulatory support.
  
  METHODS:
  A total of 54 patients (12 patients ? 70 years) were implanted with the Synergy system in an off-pump minithoracotomy procedure. Mean age (54 ± 10 vs 73 ± 3), body surface area (1.9 ± 0.2 vs 1.7 ± 0.1), blood urea nitrogen (BUN) (59 ± 33 vs 91 ± 38), estimated glomerular filtration rate (eGFR) (71 ± 23 vs 50 ± 38) and haemoglobin (12.6 ± 1.9 vs 11.3 ± 1.3) differed significantly between young and old.
  
  RESULTS:
  Older patients had longer mean durations of support (337 vs 188 days). On average, both groups showed similar improvements (changes from baseline) in haemodynamics (pulmonary capillary wedge pressure -9 ± 16 vs -10 ± 8 mmHg; CO +1.0 ± 0.7 vs 0.9 ± 1.0 l/min, periferical vascular resistance (PVR) -1.2 ± 1.5 vs = 0.8 ± 1.7 Wood) and 6 min walk (107 ± 120 vs 130 ± 121 m). Older patients showed less improvement in peak VO2 (0.5 ± 2.9 vs 1.9 ± 3.0 ml/kg/min). Major adverse events (old vs young) between groups included major bleeding (75 vs 38%), infection (25 vs 38%), renal dysfunction (0 vs 17%) and device-related stroke (8 vs 10%). Mortality rate was 20% for the young and 40% for the elderly.
  
  CONCLUSIONS:
  Older patients implanted with Synergy had smaller body sizes and worse renal function than younger patients. Both groups experienced similar haemodynamic benefits and functional improvements, though peak VO2 is less improved in the elderly. Risks of bleeding and renal dysfunction appear to be increased in the elderly, though still within acceptable ranges compared with other full support devices. Minimally invasive long-term circulatory support devices, like Synergy, offer a new treatment option to the elderly chronic heart-failure population.
  
  Guarda su PubMed

• Mitral and aortic valve prosthetic endocarditis after percutaneous closure of mitral paravalvular leak.
  Ann Thorac Surg

  2013 Feb;95(2):e45-6. doi: 10.1016/j.athoracsur.2012.08.020.
  
  Malvindi Pietro Giorgio, Raffa Giuseppe Maria, Cappai Antioco, Barbone Alessandro, Basciu Alessio, Settepani Fabrizio, Citterio Enrico, Ornaghi Diego, Tarelli Giuseppe, Vitali Ettore
  
  Abstract
  
  A 67-year-old man presented to our hospital with massive mitral and aortic valve prosthetic endocarditis 2 months after transcatheter percutaneous closure of a mitral paravalvular leak with an Amplatzer duct occluder device (AGA Medical Corp, Plymouth MN). He underwent successful reoperation for valve prosthesis replacement and reconstruction of the anterior fibrous trigone. Although transcatheter treatment of periprosthetic valve defects has been shown to be feasible, follow-up data are still limited. This procedure should be reserved only for patients who are not eligible for open surgical procedures and those with small periprosthetic defects.
  
  Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  
  Guarda su PubMed

• Left ventricular pseudoaneurysm following aortic valve prosthesis endocarditis.
  J Cardiovasc Med (Hagerstown)

  2012 Jul;13(7):457-9. doi: 10.2459/JCM.0b013e3283511f17.
  
  Malvindi Pietro G, Ornaghi Diego, Tarelli Giuseppe, Raffa Giuseppe M
  
  Abstract
  
  A 63-year-old man underwent aortic valve replacement and an early reoperation for recurrent endocarditis. Sixteen months later he presented with persistent fever and a 64-slice computed tomography (CT) scan revealed a subannular left ventricular pseudoaneurysm. He underwent successful left ventricular outflow tract reconstruction and aortic valve prosthesis, partial root and ascending aorta replacement.
  
  Guarda su PubMed

• Postsurgical aortic false aneurysm: pathogenesis, clinical presentation and surgical strategy.
  J Cardiovasc Med (Hagerstown)

  2013 Aug;14(8):593-6. doi: 10.2459/JCM.0b013e32835369f2.
  
  Raffa Giuseppe M, Malvindi Pietro G, Ornaghi Diego, Basciu Alessio, Barbone Alessandro, Tarelli Giuseppe, Settepani Fabrizio
  
  Abstract
  
  Postsurgical aortic false aneurysm occurs in less than 0.5% of all cardiac surgical cases and its management is a challenge in terms of preoperative evaluation and surgical approach. Although infections are well recognized as risk factors, technical aspects of a previous operation may have a role in pseudoaneurysm formation. The risk factors and clinical presentation of pseudoaneurysms and the surgical strategy are revisited in this article.
  
  Guarda su PubMed

• 6 months of "temporary" support by Levitronix left ventricular assist device.
  Artif Organs

  2012 Jul;36(7):639-42. doi: 10.1111/j.1525-1594.2011.01428.x.
  
  Barbone Alessandro, Malvindi Pietro Giorgio, Sorabella Robert A, Cortis Graziano, Tosi Paolo F, Basciu Alessio, Ferrara Pietro, Raffa Giuseppe, Citterio Enrico, Settepani Fabrizio, Ornaghi Diego, Tarelli Giuseppe, Vitali Ettore
  
  Abstract
  
  An otherwise healthy 47-year-old man presented to the emergency department in cardiogenic shock after suffering a massive myocardial infarction due to left main occlusion. He was initially supported by extracorporeal membrane oxygenation and subsequently was converted to paracorporeal support with a Levitronix left ventricular assist device. He experienced multiple postoperative complications including renal failure, respiratory failure, retroperitoneal hematoma requiring suspension of anticoagulation, and fungal bloodstream infection precluding transition to an implantable device. He was reconditioned and successfully underwent orthotopic heart transplant 183 days after presentation. A discussion of the relevant issues is included.
  
  © 2012, Copyright the Authors. Artificial Organs © 2012, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.
  
  Guarda su PubMed

• Bicuspidy does not affect reoperation risk following aortic valve reimplantation.
  Interact Cardiovasc Thorac Surg

  2012 Jun;14(6):717-20. doi: 10.1093/icvts/ivs059.
  
  Malvindi Pietro Giorgio, Raffa Giuseppe Maria, Basciu Alessio, Citterio Enrico, Cappai Antioco, Ornaghi Diego, Tarelli Giuseppe, Settepani Fabrizio
  
  Abstract
  
  Aortic valve reimplantation has been shown to be a safe procedure. However, evidences of durability in bicuspid aortic valves (BAVs) are limited in the literature. Between 2002 and 2011, 132 patients (mean age 61 ± 12 years) underwent aortic valve reimplantation. In 24 patients (18%), aortic valve was bicuspid. Mean follow-up was 50 ± 26 months (range 1-102 months) and was 99% complete. In-hospital mortality was 0.8% (1 patient). Survival at 1 and 5 years was 99 and 94%, respectively. Overall freedom from aortic valve reoperation at 1 and 5 years was 96 and 90%, respectively, without significant difference between patients with bicuspid and tricuspid aortic valve. Freedom from aortic valve regurgitation >2+/4+, excluding patients reoperated, was at 1 and 5 years of 100 and 99%, respectively. Patients with valve cusp repair showed a higher rate of aortic valve reoperation; however, only postoperative aortic regurgitation >2+/4+ was significant risk factor for redo procedure at multivariate analysis. Aortic valve reimplantation in BAV without cusp repair provides excellent mid-term results. Further observations and longer follow-up are necessary to determine if BAV sparing, even in the presence of cusps alterations, could allow satisfying durability.
  
  Guarda su PubMed

• Aortic valve replacement for paraprosthetic leak after transcatheter implantation.
  J Card Surg

  2012 Jan;27(1):47-51. doi: 10.1111/j.1540-8191.2011.01351.x.
  
  Raffa Giuseppe M, Malvindi Pietro Giorgio, Settepani Fabrizio, Ornaghi Diego, Basciu Alessio, Cappai Antioco, Tarelli Giuseppe
  
  Abstract
  
  Conversion to surgical aortic valve replacement (AVR) has been described as a complication following transcatheter aortic valve implantation. This complication occurs in up to 8% of cases and, to the best of our knowledge, preoperative data and surgical outcomes of such patients have not been properly evaluated. Mild paraprosthetic regurgitation is commonly observed after transcatheter aortic valve implantation and usually leads to a benign clinical course. Unequal distribution of valve calcifications is described as a potential mechanism. We report a case of a perioperative paraprosthetic regurgitation that underwent successful urgent surgical AVR and review the incidence and results of paraprosthetic leaks following transcatheter implantation.
  
  © 2011 Wiley Periodicals, Inc.
  
  Guarda su PubMed

• Compliance of the Valsalva graft's pseudosinuses at midterm follow-up with cardiovascular magnetic resonance.
  Ann Thorac Surg

  2011 Jan;91(1):92-6. doi: 10.1016/j.athoracsur.2010.09.023.
  
  Monti Lorenzo, Mauri Giovanni, Balzarini Luca, Tarelli Giuseppe, Brambilla Giorgio, Vitali Ettore, Ornaghi Diego, Citterio Enrico, Settepani Fabrizio
  
  Abstract
  
  BACKGROUND:
  In previous studies, the Valsalva graft's compliance at the level of the Dacron pseudosinuses was found similar to that of normal sinuses shortly (2±1 months) after the operation. We sought to investigate with cardiac magnetic resonance the compliance of the Valsalva graft pseudosinuses at midterm follow-up.
  
  METHODS:
  Seven patients (group A) and 7 age-matched controls (group B) were studied with steady-state free precession and phase-contrast cardiac magnetic resonance for aortic root and ascending aorta evaluation. Blood pressure was measured during phase-contrast acquisition to derive the following mechanical properties of the vascular prosthesis: pulsatility, compliance, distensibility, and elastic modulus.
  
  RESULTS:
  Mean postoperative follow-up was 55±9.84 months. Mean age was 69.2±4.98 years in group A, and 65.7±7.16 years in group B. All the studied variables were coherent in showing a significant difference between the two groups, and between aortic root (skirt portion of the graft) and ascending aorta (tubular part of the graft) in group A. The presence of periaortic fibrosis did not show any correlation with the ascending aorta's mechanical properties.
  
  CONCLUSIONS:
  At midterm follow-up, the pseudosinuses compliance of the Valsalva graft is still appreciable and significantly greater than the tubular portion.
  
  Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  
  Guarda su PubMed

• Reimplantation valve-sparing aortic root replacement with the Valsalva graft: what have we learnt after 100 cases?
  Interact Cardiovasc Thorac Surg

  2009 Jul;9(1):113-6. doi: 10.1510/icvts.2009.202622.
  
  Settepani Fabrizio, Bergonzini Marcello, Barbone Alessandro, Citterio Enrico, Basciu Alessio, Ornaghi Diego, Gallotti Roberto, Tarelli Giuseppe
  
  Abstract
  
  OBJECTIVES:
  Reimplantation valve-sparing aortic root replacement has been increasingly performed with improving perioperative and mid-term results. The success of this operation primarily depends on preserving the highly sophisticated dynamic function of the aortic valve by recreating an anatomical three-dimensional configuration similar to the normal aortic root, thus minimizing the mechanical stress and strain on the cusps. Over the years several techniques have been proposed to reproduce the sinuses of Valsalva. We reviewed our experience with aortic valve reimplantation by means of a modified Dacron graft that incorporates sinuses of Valsalva, in a series of 100 consecutive patients.
  
  METHODS:
  During a 60-month period, 100 patients with aortic root aneurysm underwent aortic valve reimplantation using the Gelweave Valsalva prosthesis. There were 74 males and the mean age was 60+/-12 years (range 28-83 years). Five patients had the Marfan's syndrome, 15 had a bicuspid aortic valve. Cusp repair was performed in five patients. The mean follow-up time was 28.6 months (range 1-60). Transesophageal echocardiogram was performed at the end of each procedure to assess the aortic valve in terms of competence, dynamic motion and level of coaptation within the graft.
  
  RESULTS:
  There was one hospital death and two late deaths. Overall survival at 60 months was 91.7+/-5.1%. Five patients developed severe aortic incompetence (AI) during follow-up requiring aortic valve replacement (AVR). The 60 months freedom from re-operation due to AI was 90.9+/-4.4%. One patient had moderate AI at latest echocardiographic study. The 60 months freedom from AI>2+ was 91.6+/-7.9%. Cox regression identified cusp's repair as independent risk factor (P=0.001) for late reimplantation failure (AVR or AI>2+). There were no episodes of endocarditis and the majority of the patients (88%) were in New York Heart Association functional class I.
  
  CONCLUSIONS:
  The aortic valve reimplantation with the Gelweave Valsalva prosthesis provided satisfactory mid-term results. An accurate assessment of the level of coaptation of the aortic cusps in respect to the lower rim of the Dacron graft by means of intraoperative transesophageal echocardiogram at the end of each procedure is mandatory in order to avoid early reimplantation failure. Cusp's repair may play an important role in the development of late AI. However, long-term results are needed in order to define the durability of this technique.
  
  Guarda su PubMed

• Reoperation for aortic false aneurysms: our experience and strategy for safe resternotomy.
  J Card Surg

  ;23(3):216-20. doi: 10.1111/j.1540-8191.2008.00597.x.
  
  Settepani Fabrizio, Muretti Mirko, Barbone Alessandro, Citterio Enrico, Eusebio Alessandro, Ornaghi Diego, Silvaggio Giuseppe, Gallotti Roberto
  
  Abstract
  
  BACKGROUND AND AIM OF THE STUDY:
  To review our experience with reoperation for aortic false aneurysms (FA) and to present an analysis of the relevant surgical approaches and risks.
  
  METHODS:
  From May 1999 to June 2006, 11 patients underwent a total of 13 reoperations due to aortic false aneurysms, with an incidence of 3% of all thoracic aortic cases. Cardiopulmonary bypass (CPB) and cooling were started before sternotomy in all cases. Three different strategies were adopted for patients depending on the position of the FA in the mediastinum as indicated by a preoperative CT scan. These included: deep hypothermic circulatory arrest (18 degrees C), moderate hypothermia (28 degrees C), and mild hypothermia (32 degrees C). In two patients, the sternotomy ruptured the FA causing profuse hemorrhaging. In all the other cases sternotomy was performed without complication. The repair consisted in simple repair by direct suture (10 cases) or extensive repair by refashioning the anastomosis (three cases).
  
  RESULTS:
  Two hospital deaths occurred with a hospital mortality rate of 16.7%. Permanent neurological deficit developed in one patient. Transient neurological deficit in the form of left lower limb weakness was observed in one patient. False aneurysm recurrence developed in two cases. Among patients present at follow-up (nine survivors), four are in NYHA class I and five in class II.
  
  CONCLUSIONS:
  Aortic false aneurysms carry a high mortality and morbidity rate. Nevertheless, we believe that selecting the right strategy according to the position of the FA in the chest can reduce surgical risk, thus permitting relatively safe resternotomy.
  
  Guarda su PubMed

• Aortic root replacement with the Carboseal composite valve graft: analysis of risk factors.
  Interact Cardiovasc Thorac Surg

  2005 Aug;4(4):360-4.
  
  Settepani Fabrizio, Eusebio Alessandro, Ornaghi Diego, Barbone Alessandro, Citterio Enrico, Manasse Eric, Silvaggio Giuseppe, Gallotti Roberto
  
  Abstract
  
  This retrospective analysis of a selected series of Bentall-De Bono procedures was carried out in order to evaluate the performance of the Carboseal composite valve graft (Sulzer Carbomedics Inc, Austin, TX, USA). Between October 1997 and April 2004, 120 patients underwent aortic root replacement with the Carboseal Composite Valve Graft. The mean age of patients was 59.7+/-13.4 years (range, 21-83 years); 96 patients (80%) were male. Eighty-nine patients (74.2%) had annulaortic ectasia, 10 patients (8.3%) post-stenotic dilatation, 3 (2.5%) post dissection aneurysm, 2 (1.7%) acute type A dissection and 1 (0.8%) endocarditis. The average follow-up duration was 29.2 months (range 2-82 months). Hospital mortality was 1.7% (2 of 120 patients). The actuarial survival rate (including hospital mortality) was 97.2+/-1.5% at 1 year, 91.6+/-3.5% at 3 years and 84.0+/-8.0% at 5 years. Chronic renal failure was an independent risk factor for late mortality (P=0.02). The actuarial freedom from pseudoaneurysms at 3 years was higher among patients without Marfan syndrome (94.7+/-3.2% vs. 75.0+/-21.6% at 3 years, P<0.003). In our recent series, the Bentall-De Bono operation provided good results with low incidence of prosthetic related complications. Pseudoaneurysms requiring re-operation have a higher incidence among patients with Marfan syndrome.
  
  Guarda su PubMed

• Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta: preliminary results.
  Interact Cardiovasc Thorac Surg

  2005 Apr;4(2):137-9.
  
  Settepani Fabrizio, Ornaghi Diego, Barbone Alessandro, Citterio Enrico, Eusebio Alessandro, Manasse Eric, Silvaggio Giuseppe, Gallotti Roberto
  
  Abstract
  
  OBJECTIVE:
  Aortic valve-sparing operations were developed to preserve the native aortic valve in patients with aneurysms of the aortic root or ascending aorta and normal aortic valve leaflets. This paper describes our initial experience with valve-sparing operations and early clinical and echocardiographic results obtained.
  
  METHODS:
  From October 2002 to March 2004, 32 consecutive patients underwent aortic valve-sparing operations at the Istituto Clinico Humanitas, Rozzano, Italy. Preoperative transesophageal echocardiography showed moderate or severe aortic incompetence (AI) in 15 patients (47%). Twenty-nine patients underwent reimplantation of the aortic valve and 3 patients remodeling of one sinus. In 2 cases prolapsing cusp repair was carried out.
  
  RESULTS:
  There were no intraoperative deaths. At discharge, two-dimensional echocardiogram showed no or trivial aortic incompetence (AI) in 17 (52%) patients and mild AI in 13 (42%); 2 (6%) patients had severe AI requiring reoperation, respectively 4 and 6 weeks later.
  
  CONCLUSIONS:
  The valve-sparing procedures showed good preliminary results, thus encouraging further use of this type of repair. However, further larger studies and long-term results are needed in order to define the durability of these techniques.
  
  Guarda su PubMed

• Early results of valve-sparing reimplantation procedure using the Valsalva conduit: a multicenter study.
  Ann Thorac Surg

  2006 Sep;82(3):865-71; discussion 871-2.
  
  Pacini Davide, Settepani Fabrizio, De Paulis Ruggero, Loforte Antonino, Nardella Saverio, Ornaghi Diego, Gallotti Roberto, Chiariello Luigi, Di Bartolomeo Roberto
  
  Abstract
  
  BACKGROUND:
  This study evaluates the midterm clinical results of valve-preserving aortic root reconstruction by means of a modified conduit incorporating sinuses of Valsalva.
  
  METHODS:
  During a 5-year period, 151 patients with aneurysm of the aortic root underwent a reimplantation type of valve-sparing procedure using the Gelweave Valsalva prosthesis that incorporates sinuses of Valsalva. There were 121 males (80.1%), and the mean age was 56.4 +/- 14.4 years (range, 14 to 83). Fourteen percent of the patients had Marfan syndrome and 8.6% had bicuspid aortic valve. Seven patients (4.6%) suffered from acute aortic dissection. Aortic replacement was extended to the arch in 14 patients (9.3%). Sixteen patients (10.6%) had associated cusp repair.
  
  RESULTS:
  In-hospital mortality was 3.3%, and it was significantly higher among patients operated on for acute dissection (p = 0.001) and in symptomatic patients (III-IV New York Heart Association class; p = 0.021). Follow-up (mean, 18 months; range, 1 to 60) was 100% complete. There were 2 late deaths. Ten patients (6.8%) had 3 to 4+ aortic regurgitation, and 8 of these required late aortic valve replacement. Cusp repair was associated with a high incidence of late aortic valve replacement (p = 0.005). At 5 years, freedom from aortic valve replacement and freedom from grade 3 to 4 aortic insufficiency was 90.8% +/- 3.3% and 88.7% +/- 3.6%, respectively.
  
  CONCLUSIONS:
  The reimplantation valve-sparing procedure with the Gelweave Valsalva prosthesis provides satisfactory results for patients with aortic root aneurysm. Aortic cusp repair may lead to late aortic insufficiency. Proper leaflet evaluation is of paramount importance in preventing residual valve regurgitation.
  
  Guarda su PubMed

• Aspergillus left ventricular assist device endocarditis.
  Ital Heart J

  2004 Nov;5(11):876-80.
  
  Barbone Alessandro, Pini Daniela, Grossi Paolo, Bandera Angelo, Manasse Eric, Citterio Enrico, Eusebio Alessandro, Silvaggio Giuseppe, Settepani Fabrizio, Municinò Annamaria, Colombo Piergiuseppe, Casari Erminia, Ornaghi Diego, Gronda Edoardo, Gallotti Roberto
  
  Abstract
  
  Left ventricular assist device (LVAD) support is an established therapy for patients with end-stage heart failure as a bridge to transplant; its usage as an alternative for those patients not eligible for transplant is not an established therapy yet. A 68-year-old male had a Thoratec-Heartmate LVAD implanted as destination therapy. After an uneventful (apart from early fever) recovery in the intensive care unit, the patient developed an intractable high temperature, and generalized sepsis and died 21 days following implant. The white cell blood count never exceeded the guard limits, and the patient succumbed with severe LVAD valve malfunction. At post-mortem examination friable material consisting of fungal hyphae was found on the inflow and outflow valves. According to published clinical trials, infection accounts for more than 40% of mortality in LVAD supported patients. Fungal LVAD endocarditis is a particularly deadly disease. Successful management requires a high level of suspicion and timely institution of antifungal therapy to control the infection. This has led some authors to recommend empiric antifungal therapy in LVAD recipients with culture-negative sepsis unresponsive to broad-spectrum antibiotics.
  
  Guarda su PubMed

• Surgical treatment of atrial fibrillation in the beating heart: a novel approach.
  Ital Heart J

  2003 Dec;4(12):872-4.
  
  Manasse Eric, Barbone Alessandro, Ghiselli Simone, Citterio Enrico, Eusebio Alessandro, Silvaggio Giuseppe, Ornaghi Diego, Gallotti Roberto
  
  Abstract
  
  Up to 50% of patients undergoing mitral valve surgery have concomitant atrial fibrillation. An epicardial approach may offer the benefit of reducing the aortic cross-clamping time and avoiding an undue left atriotomy. During the last year we have been developing a simple technique to reproduce epicardially the same lesion pattern we had previously achieved endocardially. Two patients with chronic atrial fibrillation received atrial ablation using a microwave energy probe (Flex-10, AFx Inc., Fremont, CA, USA) immediately before undergoing a concomitant cardiac procedure. The procedure is relatively quick to perform and with appropriate care can be conducted with a low risk of perioperative adverse events.
  
  Guarda su PubMed

• Cryoablation of the left posterior atrial wall: 95 patients and 3 years of mean follow-up.
  Eur J Cardiothorac Surg

  2003 Nov;24(5):731-40.
  
  Manasse Eric, Gaita Fiorenzo, Ghiselli Simone, Barbone Alessandro, Garberoglio Lucia, Citterio Enrico, Ornaghi Diego, Gallotti Roberto
  
  Abstract
  
  OBJECTIVE:
  Endocardial ablation of the left atrial posterior wall has been used to treat atrial fibrillation. Aim of the study was to evaluate its efficacy looking for the ablation pattern allowing a fast execution with limited interference on atrial contractility. Moreover a statistical analysis to identify predictors of long-term sinus rhythm recovery has been provided.
  
  METHODS:
  From April 1998 to May 2002, 95 patients with permanent (mean duration 65 months) or persistent (33%) atrial fibrillation have undergone three different ablation patterns, only 1 patient being affected by lone atrial fibrillation. Mean antero-posterior left atrial diameter was 76.2 mm. The prospective study collected information regarding variables related to patients' demographics, disease's characteristics and type of surgical ablation employed. Dependent variables were presence of sinus rhythm either at discharge and at 6 months. A logistic regression analysis was used to estimate the association between the collected variables and sinus rhythm restoration.
  
  RESULTS:
  In-hospital and late mortality rate were 3.2 and 6.3% respectively. At discharge 67 patients (72.8%) were in sinus rhythm while at a mean follow-up of 3 years, 81.4% of 86 surviving patients are in sinus rhythm. Major adverse events rate including cardiac reoperation, pace-maker implantation and cerebrovascular accident were 8.5, 6.3 and 4.2%, respectively. Pre-operative atrial fibrillation duration, left atrial dimension and type of mitral disease did not show any correlation with long term success while the lesion pattern and the rhythm at discharge were significant predictive factors. Survival is significantly higher in patients who converted to sinus rhythm at discharge (P=0.014) with respect to those who remained in atrial fibrillation.
  
  CONCLUSIONS:
  Permanent and persistent atrial fibrillation associated to a major cardiac disease can be safely treated with a linear ablation of the left atrial posterior wall. Satisfactory results in terms of rhythm restoration may be achieved regardless of the duration of the arrhythmia and its effects on atrial diameter. Any effort should be prompted to discharge patients in sinus rhythm. Life expectancy is longer if sinus rhythm is restored.
  
  Guarda su PubMed

• Left main coronary arterial lesion after microwave epicardial ablation.
  Ann Thorac Surg

  2003 Jul;76(1):276-7.
  
  Manasse Eric, Medici Dante, Ghiselli Simone, Ornaghi Diego, Gallotti Roberto
  
  Abstract
  
  We present a case of left main coronary arterial lesion in a 62-year-old man who had undergone mitral valve replacement and microwave epicardial ablation. On postoperative day 90, the patient had an anterior myocardial infarction. The coronary angiography displayed the diagnosis of the left main trunk lesion. A myocardial revascularization was urgently performed, the postoperative course was uneventful, and the patient was in sinus rhythm. The left atrial epicardial ablation represents the ultimate step in the surgical treatment of chronic atrial fibrillation; nevertheless, the left main trunk lesion may occur as an extremely severe complication. The incorrect placement of the microwave probe may be responsible for the development of critical coronary artery stenosis.
  
  Guarda su PubMed